International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 6895 - 6929
Published: July 1, 2024
This
review
aimed
to
systematically
investigate
the
intracellular
and
subcellular
fate
of
various
types
targeting
carriers.
Upon
entering
body
via
intravenous
injection
or
other
routes,
a
carrier
that
can
deliver
therapeutic
agents
initiates
their
journey.
If
administered
intravenously,
initially
faces
challenges
presented
by
blood
circulation
before
reaching
specific
tissues
interacting
with
cells
within
tissue.
At
level,
car2rier
undergoes
processes,
such
as
drug
release,
degradation,
metabolism,
through
pathways.
While
studies
on
13
carriers
have
been
relatively
conclusive,
these
are
incomplete
lack
comprehensive
analysis.
Furthermore,
there
still
whose
remains
unclear,
underscoring
need
for
continuous
research.
study
highlights
importance
comprehending
in
vivo
provides
valuable
insights
into
operational
mechanisms
different
body.
By
doing
so,
researchers
effectively
select
appropriate
enhance
successful
clinical
translation
new
formulations.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Jan. 23, 2024
Albumin
is
derived
from
human
or
animal
blood,
and
its
ability
to
bind
a
large
number
of
endogenous
exogenous
biomolecules
makes
it
an
ideal
drug
carrier.
As
result,
albumin-based
delivery
systems
are
increasingly
being
studied.
With
these
in
mind,
detailed
studies
the
transport
mechanism
carriers
particularly
important.
albumin
receptors,
glycoprotein
60
(GP60)
secreted
protein
acidic
rich
cysteine
(SPARC)
play
crucial
role
carriers.
GP60
expressed
on
vascular
endothelial
cells
enables
cross
cell
layer,
SPARC
overexpressed
many
types
tumor
cells,
while
minimally
normal
tissue
cells.
Thus,
this
review
supplements
existing
articles
by
detailing
research
history
specific
biological
functions
advances
antitumor
drugs
using
as
Meanwhile,
deficiencies
future
perspectives
study
interaction
with
also
pointed
out.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 718 - 718
Published: March 23, 2024
Cadmium
(Cd)
is
a
metal
with
no
nutritional
value
or
physiological
role.
However,
it
found
in
the
body
of
most
people
because
contaminant
nearly
all
food
types
and
readily
absorbed.
The
burden
Cd
determined
principally
by
its
intestinal
absorption
rate
as
there
mechanism
for
elimination.
Most
acquired
accumulates
within
kidney
tubular
cells,
where
levels
increase
through
to
age
50
years
but
decline
thereafter
due
release
into
urine
injured
cells
die.
This
associated
progressive
disease,
which
signified
sustained
estimated
glomerular
filtration
(eGFR)
albuminuria.
Generally,
reductions
eGFR
after
exposure
are
irreversible,
likely
further
towards
failure
if
persists.
There
evidence
that
elimination
current
environmental
can
reverse
these
effects
theoretical
reason
believe
such
reversal
possible.
review
aims
provide
an
update
on
urinary
blood
were
be
GFR
loss
albuminuria
general
populations.
A
special
emphasis
placed
mechanisms
underlying
albumin
excretion
Cd-exposed
persons,
accurate
measure
doses-response
relationships
between
eGFR,
must
normalised
creatinine
clearance.
difficult
challenge
establishing
realistic
guidelines
human
health
protected,
discussed.
Cadmium
(Cd)
is
a
metal
with
no
nutritional
or
physiological
value,
but
found
in
most
people
because
it
contaminant
nearly
all
food
types.
The
intestinal
absorption
rate
determines
the
body
burden
of
Cd
humans
lack
physiologic
mechanism
for
excretion
metal.
Most
acquired
accumulates
kidneys,
which
content
increases
through
age
50
falls
thereafter.
decline
from
maximal
kidney
probably
due
to
release
injured
tubular
cells
into
urine
and
replacement
destroyed
nephrons
by
scar
tissue.
Chronic
disease
diagnosed
when
estimated
glomerular
filtration
(eGFR)
below
60
mL/min/1.73
m2,
albuminuria
present.
Albuminuria
defined
as
an
albumin-to-creatinine
ratio
≥
30
mg/g
creatinine
women
20
men
that
persists
at
least
3
months.
Generally,
Cd-induced
reductions
eGFR
are
not
reversible,
nephropathy
may
progress
end-stage
disease.
There
evidence
elimination
current
environmental
exposure
can
reverse
nephropathy,
theoretical
reason
believe
such
reversal
possible.
This
review
provides
update
knowledge
concerning
CKD
population
environmentally
exposed
Cd.
Special
attention
devoted
mechanisms
concurrently
reductions,
difficult
challenge
guidelines
sufficient
eliminate
risk
addressed.
Sensors,
Journal Year:
2022,
Volume and Issue:
22(18), P. 6889 - 6889
Published: Sept. 13, 2022
Bioengineered
in
vitro
models
of
the
kidney
offer
unprecedented
opportunities
to
better
mimic
vivo
microenvironment.
Kidney-on-a-chip
technology
reproduces
2D
or
3D
features
which
can
replicate
tissue
architecture,
composition,
and
dynamic
mechanical
forces
experienced
by
cells
vivo.
Kidney
are
exposed
stimuli
such
as
substrate
stiffness,
shear
stress,
compression,
stretch,
regulate
multiple
cellular
functions.
Incorporating
kidney-on-a-chip
is
critically
important
for
recapitulating
physiological
pathological
This
review
will
explore
approaches
applying
different
cell
types
using
how
these
systems
used
study
physiology,
model
disease,
screen
drug
toxicity.
We
further
discuss
sensor
integration
into
monitoring
responses
other
stimuli.
advantages,
limitations,
challenges
associated
with
incorporating
a
variety
applications.
Overall,
this
aims
highlight
importance
design
implementation
devices.
Journal of Nuclear Medicine,
Journal Year:
2022,
Volume and Issue:
63(10), P. 1475 - 1479
Published: July 14, 2022
Single-domain
antibody
(sdAb)
is
among
the
most
promising
vectors
for
developing
molecular
imaging
tracers.
Several
sdAb
tracers
targeting
human
epidermal
growth
factor
receptor
2
or
programmed
death
ligand
1
have
entered
clinical
practice.
However,
radiolabeled
single-valent
sdAbs
generally
high
kidney
retention,
limiting
their
therapeutic
applications.
Therefore,
engineering
strategies
such
as
PEGylation
incorporation
of
renal
cleavable
linkers
can
be
adapted
to
improve
pharmacokinetics
and
reduce
retention.
In
this
Focus
on
Molecular
Imaging
review,
we
try
summarize
latest
developments
in
sdAb-derived
agents
propose
potential
that
used
theranostic
value
sdAbs.
Nano-Micro Letters,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: Dec. 4, 2023
Ultrasmall
gold
nanoparticles
(AuNPs)
typically
includes
atomically
precise
nanoclusters
(AuNCs)
and
AuNPs
with
a
core
size
below
3
nm.
Serving
as
bridge
between
small
molecules
traditional
inorganic
nanoparticles,
the
ultrasmall
show
unique
advantages
of
both
(e.g.,
rapid
distribution,
renal
clearance,
low
non-specific
organ
accumulation)
long
blood
circulation
enhanced
permeability
retention
effect).
The
emergence
creates
significant
opportunities
to
address
many
challenges
in
health
field
including
disease
diagnosis,
monitoring
treatment.
Since
nano–bio
interaction
dictates
overall
biological
applications
AuNPs,
this
review
elucidates
recent
advances
interactions
imaging
AuNPs.
We
begin
introduction
factors
that
influence
cellular
then
discuss
interactions,
especially
focus
on
liver
kidneys.
further
present
tumor
In
addition,
performance
is
summarized
discussed.
Finally,
we
summarize
provide
some
perspective
future
research
direction
aiming
accelerate
their
clinical
translation.